Roche Holding AG (LTS:0QOK)
CHF 263.05 -1.65 (-0.62%) Market Cap: 211.30 Bil Enterprise Value: 236.93 Bil PE Ratio: 19.78 PB Ratio: 7.21 GF Score: 86/100

Full Year 2021 Roche Holding AG Earnings Presentation Transcript

Feb 03, 2022 / 01:00PM GMT
Release Date Price: CHF350 (-2.23%)

Feb 03, 2022 / 01:00PM GMT
Presentation
Feb 03, 2022 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
* Severin Schwan
Roche Holding AG - CEO & Executive Director
* Thomas Schinecker
Roche Holding AG - CEO of Roche Diagnostics
* William N. Anderson
Roche Holding AG - CEO of Roche Pharmaceuticals

=====================
Conference Call Participants
=====================
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Luisa Caroline Hector
Joh. Berenberg, Gossler & Co. KG, Research Division - Co-Head of Global Pharmaceutical Team
* Matthew Weston
Crédit Suisse AG, Research Division - MD and Co-Head of European Pharmaceutical Equity Research
* Michael Leuchten
UBS Investment Bank, Research Division -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot